Penetration enhancers for transdermal delivery of systemic agent

Details Penetration enhancers for transdermal delivery of systemic agent Penetration enhancers for transdermal delivery of systemic agent

1994-10-20

1995-08-22

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514182, 514356, 514420, 514470, 514567, 514633, 514650, 514788, 514947, A61K 31445, A61K 3156, A61K 3144, A61K 3140, A61K 3134, A61K 31195, A61K 31155, A61K 31135, A61K 4700

Patent

active

054440750

ABSTRACT:
This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals and into the blood stream in a transdermal device or formulation comprising topically administering with said systemic agent an effective amount of a membrane penetration enhancer.

REFERENCES:
patent: 4845081 (1989-07-01), Sloan
patent: 4902676 (1990-02-01), Peck et al.
patent: 5128376 (1992-07-01), Saito et al.

Affiliated with

Also associated with

Rating

Penetration enhancers for transdermal delivery of systemic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Penetration enhancers for transdermal delivery of systemic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Penetration enhancers for transdermal delivery of systemic agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2142116